Skip to main content

Table 2 Top proteins with higher or lower levels in participants with IPF versus controls. Proteins with a |log2FC| > 0.585 (i.e. a > 1.5-fold difference in protein concentration between groups) and a false discovery rate (FDR)-corrected p Value < 0.05 are shown

From: Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

Gene

Aptamer ID

Protein

log2FC

p Value

FDR adjusted p Value

Higher levels in participants with IPF versus controls

 PGAM1

3896–5

Phosphoglycerate mutase 1

1.260

9.00E-08

9.24E-07

 GPD1

11,081–1

Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic

1.224

4.95E-19

3.08E-17

 THBS1

3474–19

Thrombospondin-1

1.203

1.46E-16

6.55E-15

 VWF

3050–7

von Willebrand factor

1.136

3.68E-32

1.20E-29

 CCL17

3519–3

C-C motif chemokine 17

1.053

2.38E-16

1.03E-14

 BPI

4126–22

Bactericidal permeability-increasing protein

1.031

7.26E-15

2.37E-13

 OLR1

3636–37

Oxidised low-density lipoprotein receptor 1

0.929

4.84E-32

1.26E-29

 CAPG

4968–50

Macrophage-capping protein

0.882

1.09E-28

1.43E-26

 SPARC

3043–49

SPARC

0.869

3.13E-15

1.13E-13

 FN1

4131–72

Fibronectin

0.864

1.19E-30

2.59E-28

 PF4

2697–7

Platelet factor 4

0.853

7.84E-08

8.32E-07

 PPBP

4544–4

Connective tissue-activating peptide III

0.850

2.74E-08

3.26E-07

 PPBP

2790–54

Neutrophil-activating peptide 2

0.844

3.23E-08

3.73E-07

 ICAM5

5124–69

Intercellular adhesion molecule 5

0.841

4.10E-34

1.78E-31

 CXCL13

3487–32

C-X-C motif chemokine 13

0.834

1.63E-15

6.27E-14

 PGD

4187–49

6-phosphogluconate dehydrogenase, decarboxylating

0.833

7.64E-07

6.39E-06

 C1R

3285–23

Complement C1r subcomponent

0.825

3.39E-29

5.49E-27

 HIST1H1C

2987–37

Histone H1.2

0.808

1.58E-07

1.56E-06

 MMP9

2579–17

Matrix metalloproteinase-9

0.792

4.49E-16

1.83E-14

 SFTPD

4414–69

Pulmonary surfactant-associated protein D

0.789

1.75E-08

2.20E-07

 GDF15

4374–45

Growth/differentiation factor 15

0.782

2.32E-28

2.75E-26

 S100A9

5339–49

Protein S100-A9

0.778

9.08E-18

4.74E-16

 FN1

3434–34

Fibronectin fragment 3

0.770

3.78E-29

5.49E-27

 PDGFB

4149–8

Platelet-derived growth factor subunit B

0.768

7.67E-08

8.25E-07

 CCL18

3044–3

C-C motif chemokine 18

0.734

2.31E-29

4.31E-27

 ANXA6

5335–73

Annexin A6

0.725

3.36E-09

4.82E-08

 MMP1

4924–32

Matrix metalloproteinase-1

0.712

3.92E-11

8.25E-10

 TIMP3

2480–58

Metalloproteinase inhibitor 3

0.690

4.04E-10

7.32E-09

 VAV1

5275–28

Proto-oncogene vav

0.687

8.31E-05

4.15E-04

 HNRNPA2B1

5351–52

Heterogeneous nuclear ribonucleoproteins A2/B1

0.683

2.27E-12

5.69E-11

 PDGFA

4499–21

Platelet-derived growth factor subunit A

0.665

3.05E-08

3.55E-07

 APP

3171–57

Amyloid-beta A4 protein

0.662

1.34E-11

2.97E-10

 S100A6

13,090–17

Protein S100-A6

0.625

4.47E-14

1.33E-12

 CCL5

5480–49

C-C motif chemokine 5

0.614

3.43E-07

3.15E-06

 C4A C4B

2182–54

Complement C4A and C4B

0.604

1.13E-08

1.49E-07

 CCL22

3508–78

C-C motif chemokine 22

0.599

6.96E-18

3.95E-16

 HK2

13,130–150

Hexokinase-2

0.592

2.22E-09

3.35E-08

Lower levels in participants with IPF versus controls

 MMP3

2788–55

Stromelysin-1

−1.343

2.77E-36

1.81E-33

 CKB CKM

3714–49

Creatine kinase B-type; Creatine kinase M-type

−1.325

4.95E-22

4.04E-20

 ADSL

5023–23

Adenylosuccinate lyase

−1.126

2.70E-26

2.93E-24

 SHH

2743–5

Sonic hedgehog protein

−0.852

7.35E-26

7.38E-24

 CA6

3352–80

Carbonic anhydrase 6

−0.778

2.15E-15

8.01E-14

 AGER

4125–52

Advanced glycosylation end product-specific receptor

−0.770

5.74E-20

3.74E-18

 HSPB1

11,103–24

Heat shock protein beta-1

−0.734

1.46E-05

9.18E-05

 TFF1

9185–15

Trefoil factor 1

−0.708

1.20E-12

3.20E-11

 PRKCA

2644–11

Protein kinase C alpha type

−0.695

3.68E-04

1.54E-03

 PRKACA

3466–8

cAMP-dependent protein kinase catalytic subunit alpha

−0.590

7.02E-05

3.63E-04

  1. p Values are shown as exponentiated values